Stock Earnings

Question 1

What are Pulmonx Corp's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Pulmonx Corp has a total asset of $162, Net loss of $-56

Question 2

What are the key financial ratios for LUNG?

Accepted Answer

Pulmonx Corp's Current ratio is 2.1, has a Net margin is -67.46, sales per share of $2.12.

Question 3

How is Pulmonx Corp's revenue broken down by segment or geography?

Accepted Answer

Pulmonx Corp largest revenue segment is Interventional Pulmonology, at a revenue of 83,789,000 in the most earnings release.For geography, United States is the primary market for Pulmonx Corp, at a revenue of 56,465,000.

Question 4

Is Pulmonx Corp profitable?

Accepted Answer

no, according to the latest financial statements, Pulmonx Corp has a net loss of $-56

Question 5

Does Pulmonx Corp have any liabilities?

Accepted Answer

yes, Pulmonx Corp has liability of 77

Question 6

How many outstanding shares for Pulmonx Corp?

Accepted Answer

Pulmonx Corp has a total outstanding shares of 39.78

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	91	83	68	53	48	32
Revenue Growth (YoY)	15%	22%	28%	10%	50%	0%
Cost of Revenue	24	21	17	13	12	11
Gross Profit	67	62	50	39	35	21
Selling, General & Admin	105	102	94	83	69	46
Research & Development	18	15	18	15	13	7
Operating Expenses	124	118	112	98	82	53
Other Non Operating Income (Expenses)	0	0	0	0	0	3
Pretax Income	-56	-55	-60	-58	-48	-32
Income Tax Expense	0	0	0	0	0	0
Net Income	-56	-56	-60	-58	-48	-32
Net Income Growth	0%	-7%	3%	21%	50%	60%
Shares Outstanding (Diluted)	40.93	39.11	37.97	37.1	36.13	35.69
Shares Change (YoY)	5%	3%	2%	3%	1%	5%
EPS (Diluted)	-1.38	-1.44	-1.6	-1.59	-1.35	-0.9
EPS Growth	-6%	-10%	1%	18%	50%	48%
Free Cash Flow	-32	-32	-38	-46	-45	-31
Free Cash Flow Per Share	-0.78	-0.81	-1	-1.23	-1.24	-0.86
Gross Margin	73.62%	74.69%	73.52%	73.58%	72.91%	65.62%
Operating Margin	-62.63%	-67.46%	-89.7%	-109.43%	-97.91%	-100%
Profit Margin	-61.53%	-67.46%	-88.23%	-109.43%	-100%	-100%
Free Cash Flow Margin	-35.16%	-38.55%	-55.88%	-86.79%	-93.75%	-96.87%
EBITDA	-56	-55	-60	-57	-47	-32
EBITDA Margin	-61.53%	-66.26%	-88.23%	-107.54%	-97.91%	-100%
D&A For EBITDA	1	1	1	1	0	0
EBIT	-57	-56	-61	-58	-47	-32
EBIT Margin	-62.63%	-67.46%	-89.7%	-109.43%	-97.91%	-100%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Pulmonx Corp (LUNG) Price

LUNG Stock Price Chart

LUNG Income

Follow-Up Questions